Safety and efficiency of SGLT2 inhibitor combining with insulin in subjects with diabetes
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference36 articles.
1. The changing epidemiology of type 1 diabetes: why is it going through the roof?;Vehik;Diabetes Metab Res Rev,2011
2. The role of sodium-glucose co-transporter 2 inhibitors in the treatment of type 2 diabetes;Whalen;Clin Ther,2015
3. Sodium-glucose cotransporter 2 inhibitors: the new option for diabetes mellitus management;Powell;South Med J,2015
4. The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus;Vallon;Annu Rev Med,2015
5. Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitus;Fioretto;Cardiovasc Diabetol,2015
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. SGLT2 inhibitor use in the management of feline diabetes mellitus;Journal of Veterinary Pharmacology and Therapeutics;2024-07-02
2. The effects of SGLT2 inhibitors in patients with metabolic dysfunction-associated fatty liver disease; a narrative review;Journal of Mind and Medical Sciences;2024-04-30
3. Metabolic effects of glyphlozines;Vnitřní lékařství;2024-04-10
4. Impact of empagliflozin on insulin needs in patients with heart failure and diabetes: An EMPEROR‐Pooled analysis;Diabetes, Obesity and Metabolism;2024-04
5. Inhibition of Sodium-Glucose Cotransporter-2 during Serum Deprivation Increases Hepatic Gluconeogenesis via the AMPK/AKT/FOXO Signaling Pathway;Endocrinology and Metabolism;2024-02-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3